Effects of granulocyte-colony-stimulating factor and interleukin-2 on ascites formation and the survival time of nude mice bearing human ovarian cancer cells Y. KikuchiEiji ImaizumiIchiro Nagata ORIGINAL ARTICLE Pages: 257 - 261
Antigen-presenting function of human peritoneum mesothelial cells isolated from a pancreatic carcinoma patient after mutant Ras peptide vaccination M. K. GjerstenIngvil SæterdalGustav Gaudernack ORIGINAL ARTICLE Pages: 262 - 268
Treatment of human lung carcinoma xenografts with a combination of 131I-labelled monoclonal antibody Po66 and doxorubicin B. DesruesF. BrichoryL. Dazord ORIGINAL ARTICLE Pages: 269 - 274
Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-γ secretion Øystein BruserudLaila MentzoniIngerid Nesthus ORIGINAL ARTICLE Pages: 275 - 282
Interleukin-2 and interleukin-7 augment the cytolytic activity and expand the antitumor killing spectrum of α CD3-induced activated killer cells: potential use in the immunotherapy of non-immunogenic tumors Chou-Chik TingJ. WangYili Yang ORIGINAL ARTICLE Pages: 283 - 292
Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2 Rutger L. van BezooijenH. GoeyG. J. Fleuren ORIGINAL ARTICLE Pages: 293 - 298
Levamisole regulates the proliferation of murine liver T cells through Kupffer-cell-derived cytokines John A. JohnkoskiSteven M. PetersonS. A. Cohen ORIGINAL ARTICLE Pages: 299 - 306
Autoantibody to p185 erbB2/neu oncoprotein by vaccination with xenogenic DNA A. ConcettiA. AmiciF. M. Venanzi ORIGINAL ARTICLE Pages: 307 - 315